Summer 2026
Plant Intern
Clorox
5,001-10,000 employees
Manufactures and markets consumer cleaning products
Compensation Overview
$20/hr
No H1B Sponsorship
Somerset, KY, USA
In Person
On-site internship in Burnside, KY; local candidates preferred.
US Citizenship Required
 General Maintenance & Repair (1) |
|---|
Get referred to Clorox
See people who can refer or advise you
- Completed 1+ years in SCC Industrial Maintenance Program
- Excellent communication & interpersonal skills
- Self-motivated
- Functions well within a team environment
- Minimum Cumulative or Engineering Department GPA ≥ 3.0
- Demonstrates strong ethical standards
- Adapts well to business / project needs
- Is currently a US Citizen / Permanent Resident (Sponsorship Unneeded)
- Supporting the different plant processes (Briquetting, Retort, Packaging)
- Working with the maintenance department.
- Working within the suggested summer schedule May 13th– August 2nd
Clorox makes and sells cleaning supplies, household products, and some food products through a portfolio of well-known brands. Its products are offered to both consumers and professional users and distributed via mass merchandisers, grocery stores, and online channels around the world. How the products work: cleaning and disinfecting products are used to sanitize and maintain surfaces and homes, while household items and food-related products support everyday routines. How it stands out: instead of relying on a single product or category, Clorox combines a broad brand lineup with sales across multiple markets and customer channels, giving it broad reach and stability. Its goal is to provide trusted brands that help people keep spaces clean and safe while meeting the needs of both individual consumers and professional customers.
Company Size
5,001-10,000
Company Stage
IPO
Headquarters
Oakland, California
Founded
1913
Get referred to Clorox
See people who can refer or advise you
Simplify's Take
What believers are saying
- GOJO added about 10 points to Q4 sales and supports 13% to 14% FY27 growth.
- Clorox finished its five-year U.S. ERP rollout, reducing shipment disruption and visibility risk.
- Pine-Sol TikTok Shop scents sold out within hours, validating direct-to-consumer experimentation.
What critics are saying
- Organic sales fell 13% in Q4 fiscal 2026, exposing weak underlying demand.
- Linda Rendle's exit creates leadership uncertainty during margin repair and GOJO integration.
- The Cognizant lawsuit over the 2023 cyberattack keeps operational failures and damages alive.
What makes Clorox unique
- Clorox Purell broadens health-and-hygiene reach with GOJO's April 2026 acquisition.
- Pine-Sol's TikTok Shop scents test social-first innovation and younger consumer relevance.
- Clorox PURE allergen-neutralizer and Clorox Healthcare launches extend the brand beyond bleach.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
401(k) Retirement Plan
401(k) Company Match
Unlimited Paid Time Off
Family Planning Benefits
Fertility Treatment Support
Wellness Program
Mental Health Support
Company News
Clorox reported fourth-quarter fiscal 2026 results ending 30 June, with net sales decreasing 2% to $1.95 billion. The company completed its acquisition of GOJO Industries in April 2026, which added approximately 10 percentage points to sales. Organic sales fell 13%, primarily due to lapping incremental shipments related to an ERP transition. Diluted earnings per share dropped 50% to $1.34 from $2.68 year-over-year. Gross margin decreased 520 basis points to 41.3%. For fiscal 2027, Clorox expects net sales growth of 13% to 14%, including 9.5 points from the GOJO acquisition. Organic sales are projected to increase 3.5% to 4.5%. Adjusted EPS is forecast between $5.70 and $6.00, representing growth of 3% to 8%. The company completed its five-year US ERP implementation during the fiscal year.
Clorox faces a challenging outlook ahead of its June 2026 quarter earnings call on 3 August. Analysts expect quarterly earnings of $1.64 per share and revenues of $1.91 billion, representing year-over-year declines. The company's weaker forecast is accompanied by bearish analyst sentiment, including a negative Earnings ESP and lower independent ranking. These factors highlight concerns about Clorox's near-term earnings trajectory. In April, Clorox cut its fiscal 2026 guidance, projecting net sales to fall approximately 6% and diluted EPS between $4.78 and $4.98. The company attributes the weakness to demand pressures and cost headwinds, despite the GOJO acquisition and VMS divestiture. Success will depend on whether its ERP rollout and late fiscal 2026 product launches can offset current pressures from value-seeking consumers and aggressive competition.
Clorox has returned $3.8 billion to shareholders over the past five years through dividends and buybacks, representing 33% of its current market capitalisation. Despite this substantial payout, the stock has fallen 37% during that period, whilst the S&P 500 gained 82%. The consumer staples company generates $6.76 billion in annual revenue from household brands. Management attributes the stock's underperformance to slower-than-expected business improvements and execution challenges. Key initiatives, including the Fresh Step litter brand reinvention, have faced difficulties. Clorox's capital return programme significantly exceeds the S&P 500 median of 16.6% of market value, reflecting a mature business generating excess cash. However, operational struggles have left the stock trading around $96.32, approximately 40% below its two-year high.
Jim Cramer advised investors to wait before buying semiconductor stocks, warning that margin-driven forced selling hasn't finished. He told viewers during his 17 July Mad Money show to hold off until speculative sellers exit the market, saying "you're going to find a bottom. I don't see it yet." Cramer specifically cautioned against Nebius Group, which dropped 35% in one month, stating hedge funds face trouble and "this stock is not done going down." Instead, he recommended defensive dividend plays. Cramer backed Clorox for its 5% yield and 0.53 beta, citing a recent positive analyst note with a price target increase. He favoured Coca-Cola over Coca-Cola Consolidated amid aluminium tariff margin pressures, and suggested Quanta Services' record $48.5 billion backlog could reward patient buyers following a 12% share pullback.
Clorox has acquired hand sanitiser brand Purell for $2.25 billion, boosting its position in the health and hygiene sector. The deal expands Clorox's commercial sales channels and is expected to generate new revenue streams whilst strengthening its market position. Clorox's stock rose 3.58% to a 20-day high following the announcement, outperforming a challenging market environment where the Nasdaq-100 fell 1.98% and the S&P 500 dropped 0.86%. The acquisition is viewed as part of Clorox's long-term growth strategy as it navigates challenges from an enterprise resource planning system transition. The deal enhances Clorox's product portfolio in the health and hygiene category.